Amphetamine (Adderall). Doxepin. Fluvoxamine. Paxil. Atomoxetine When compared to a CYP2D6 normal metabolizer, a poor metabolizer may.
ABILIFY MAINTENA Dosage Adjustments for Cytochrome P450 Considerations, Chart; Factors ABILIFY MAINTENA adjusted dose ABILIFY MAINTENA adjusted dose; CYP2D6 poor metabolizers: Known CYP2D6 poor metabolizers: 300 mg once monthly: Known CYP2D6 poor metabolizers taking concomitant CYP3A4 inhibitors: 200 mg once monthly: Patients taking
CYP2D6 Poor Metabolizers: Dosage adjustment is recommended in patients known to be poor CYP2D6 metabolizers because these patients have higher dextromethorphan
200-mg and 160-mg dosage adjustments are obtained only by using the 300-mg or 400-mg strength vials. CYP2D6 Poor Metabolizers: Known CYP2D6 Poor Metabolizers: 300 mg: Known CYP2D6 Poor Metabolizers taking concomitant CYP3A4 inhibitors: 200 mg Patients Taking 400 mg of ABILIFY MAINTENA: Strong CYP2D6 or CYP3A4 inhibitors: 300 mg: CYP2D6 and
ABILIFY ASIMTUFII Dosage Recommendations for Cytochrome P450 Considerations, Chart; Factors ABILIFY ASIMTUFII adjusted dose; CYP2D6 poor metabolizers; Known CYP2D6 poor metabolizers: 720 mg once every 2 months: Known CYP2D6 poor metabolizers taking concomitant CYP3A4 inhibitors: Avoid use: Patients taking ABILIFY ASIMTUFII
CYP2D6 poor metabolizers: Dextromethorphan is metabolized by hepatic CYP2D6. Poor metabolizers of CYP2D6 may have exaggerated or prolonged effects of dextromethorphan. Increased risk may be seen with concomitant use of potent CYP2D6 inhibitors; use with caution (Abduljalil 2024; Jurica 2024; Sager 2024; Zhou 2024).
ABILIFY ASIMTUFII Dosage Recommendations for Cytochrome P450 Considerations, Chart; Factors ABILIFY ASIMTUFII adjusted dose; CYP2D6 poor metabolizers; Known CYP2D6 poor metabolizers: 720 mg once every 2 months: Known CYP2D6 poor metabolizers taking concomitant CYP3A4 inhibitors: Avoid use: Patients taking ABILIFY ASIMTUFII
Dosage Recommendations for Known CYP2D6 Poor Metabolizers (PMs): The recommended dosage for patients known to be poor CYP2D6 metabolizers is one tablet once
CYP2D6 poor metabolizer phenotype is significantly associated with higher odds of Adderall (dextroamphetamine saccharate, amphetamine aspartate
For clarity's sake, Biphetamine was a mixture of amphetamine salts and (for practical purposes) the same as Adderall.